"Executive Summary:               VEGF-A Inhibitors is a rapidly growing segment within the broader oncology and drug development landscape, driven by the increasing recognition of vascular endothelial growth factor-C (VEGF-C) as a key factor in the development of lymphatic vessels and the progression of various cancers. VEGF-C plays a critical role in...